Strategic Design of Catalytic Lysine‐Targeting Reversible Covalent BCR‐ABL Inhibitors**

Author:

Quach David12,Tang Guanghui3,Anantharajan Jothi2,Baburajendran Nithya2,Poulsen Anders2,Wee John L. K.2,Retna Priya2,Li Rong2,Liu Boping2,Tee Doris H. Y.2,Kwek Perlyn Z.2,Joy Joma K.2,Yang Wan‐Qi4,Zhang Chong‐Jing4,Foo Klement2,Keller Thomas H.2,Yao Shao Q.13ORCID

Affiliation:

1. NUS Graduate School for Integrative Sciences and Engineering 21 Lower Kent Ridge, University Hall, Tan China Tuan Wing, #04-02 Singapore 119077 Singapore

2. Experimental Drug Development Centre 10 Biopolis Road, Chromos, #05-01 Singapore 138670 Singapore

3. Department of Chemistry National University of Singapore Singapore 117543 Singapore

4. State Key Laboratory of Bioactive Substances and Functions of Natural Medicines and Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation Institute of Materia Medica Peking Union Medical College and Chinese Academy of Medical Sciences Beijing 100050 China

Funder

National Research Foundation Singapore

National Medical Research Council

Publisher

Wiley

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3